There was no such charge during the three months ended June 30, 2018.
The tax provision for the three months ended June 30, 2018 was primarily driven by the income generated during the quarter.
severance in the Brooks Semiconductor Solutions Group segment.
During the three months ended June 30, 2018, the net loss included $0.7 million related to the step-up in value of the acquired inventories and $1.0 million related to amortization expense of acquired intangible assets.
There were no transaction costs related to the 4titude acquisition during the three months ended June 30, 2018.
Net foreign currency transaction and remeasurement losses totaled $0.6 million and $0.7 million, respectively, during the three months ended June 30, 2018 and 2017, and $3.1 million and $1.6 million, respectively, during the nine months ended June 30, 2018 and 2017.
reporting unit within the Brooks Semiconductor Solutions Group segment and for the Brooks Life Science Systems reporting unit.
The acquisition of 4titude will expand the Company’s existing offerings of consumables and instruments within the Brooks Life Sciences segment.
 Amortization expense for intangible assets was $17.7 million and $12.7 million, respectively, during the nine months ended June 30, 2018 and 2017.
During the nine months ended June 30, 2018, the net loss also included non-recurring charges of $1.2 million related to the step-up in value of the acquired inventories.Gross margin was 39.9% for the third quarter of fiscal year 2018 as compared to 39.4% for the third quarter of fiscal year 2017, which resulted in an increase in gross profit of $17.7 million.
Gross margin increased in the Brooks Semiconductor Solutions Group segment by 0.6 percentage points and in the Brooks Life Sciences segment by 0.7 percentage points in the 2018 period over the 2017 period.
Gross margin was 40.1% for the nine months ended June 30, 2018 as compared to 37.8% for the nine months ended June 30, 2017, which resulted in an increase in gross profit of $55.6 million.
We have one customer within the Brooks Semiconductor Solutions Group segment that accounted for approximately 12% and 10% of our consolidated revenue for the nine months ended June 30, 2018 and 2017, respectively.
There were no such charges during the three months ended June 30, 2018.
Gross margin increased in the Brooks Semiconductor Solutions Group segment by 3.1 percentage points and 0.1 points in the Brooks Life Sciences segment in the 2018 period, as compared to the prior period.
 During the three and nine months ended June 30, 2018, we recorded income of $1.3 million and $4.9 million, respectively, from our equity method investments as compared to $2.5 million and $7.2 million, respectively, during the corresponding periods of the prior fiscal year.
Please refer to the “Liquidity and Capital Resources” section below for further information on the term loan.